Corteva (NYSE:CTVA) Issues FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.760-0.800 for the period, compared to the consensus EPS estimate of 1.070.

Corteva Price Performance

Shares of NYSE CTVA traded up $0.03 during midday trading on Wednesday, reaching $12.20. 12,838,632 shares of the company were exchanged, compared to its average volume of 8,011,878. The stock’s 50-day moving average price is $41.93 and its 200-day moving average price is $70.50. The stock has a market cap of $8.14 billion, a P/E ratio of 8.08, a PEG ratio of 1.69 and a beta of 0.58. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. Corteva has a one year low of $11.24 and a one year high of $90.97.

Corteva Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be issued a dividend of $0.05 per share. This is a negative change from Corteva’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $0.20 annualized dividend and a dividend yield of 1.6%. Corteva’s dividend payout ratio (DPR) is 13.25%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Bank of America boosted their price objective on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. UBS Group dropped their target price on Corteva to $15.00 and set a “neutral” rating for the company in a research report on Monday, October 12th. KeyCorp raised Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 price target on the stock in a research note on Wednesday, October 7th. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Finally, Royal Bank Of Canada restated an “outperform” rating and set a $17.00 price target on shares of Corteva in a report on Wednesday, October 7th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and an average target price of $60.59.

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.